Qualigen Therapeutics, Inc. Elects Tariq Arshad as Its Senior Vice President and Chief Medical Officer
Qualigen Therapeutics, Inc. announced that on May 17, 2021, the Board elected Tariq Arshad as its Senior Vice President and Chief Medical Officer. This is a newly-created position. Mr. Arshad was previously Global Head of Medical Affairs and Clinical Research with Becton Dickinson Biosciences (2019-2021), Head of Medical Affairs, Immunology, Global Markets for Sanofi Genyzyme (2018-2019) and Chief Medical Officer, Head of Clinical Research and Medical Affairs for Humanigen, Inc. (2016-2018). Before then, he held medical leadership positions with XOMA Corporation, Genentech, Inc., Merck & Co., Inc. and Pfizer Inc. Mr. Arshad is a medical doctor with a specialization in oncology and also holds a M.B.A. degree.